Sujal Patel and Parag Mallick founded Nautilus Biotechnology to revolutionize biomedicine by unlocking the power of the proteome. As the Nautilus platform shifts from a theoretical idea to a commercial product, learn how the founders believe the proteomics revolution will drastically alter research, healthcare, and other aspects of science.
This post includes several interviews with the founders and should give you a sense of their vision for the Nautilus Proteome Analysis Platform, company culture, and the world of science in general.
In February 2022, Parag and Sujal sat down (virtually) with BIOS to discuss how Sujal’s business acumen and Parag’s scientific expertise contribute to the development and success of both Nautilus’ technology and the company itself.
In a quick interview with Bloomberg Technology, Sujal describes Nautilus’s new platform and how this technology may drastically improve the scope of proteome coverage. The Nautilus Proteome Analysis Platform is designed to comprehensively cover 95% of the proteome and will potentially pave the way for breakthroughs in therapeutic research and development.
Parag joins Drew and Liv, two graduate students early in their scientific careers, to discuss how his academic background spanning computer science and biochemistry shaped his career. He also addresses ways in which the Nautilus platform could reshape everyday research and medicine.
Few scientists can claim to have been featured in Vanish, the international magic magazine. Parag, scientist by day, magician by night, used the opportunity to explore the interconnection between science and magic and uncover how our perceptions create cognitive gaps in how we see the world. These holes in our perception are the key to a magician’s tricks, but they can drastically limit scientific progress, making identification of cognitive gaps a point of interest for magicians and scientists alike.
While there is plenty of uncertainty in the air, in an interview with Geek Wire, Sujal offers some words of optimism regarding company strategy and acquisition of new talent during 2023. The growth of Nautilus’ platform will continue to require efficient spending, but Sujal plans to leverage the high quality applicant pool to increase the overall experience and strength of the company.
Follow @NautilusBio on LinkedIn and Twitter to hear more about our company, technology, and founders.
© 2023 Nautilus Biotechnology Inc.
All Rights Reserved.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |